Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Gabriel Lopez-Berestein
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Chemicals & Drugs
Living Beings
Anatomy
Disorders
Physiology
Sign-in to see full Profile
Network (preview)
22
Tari, Ana
20
Sood, Anil
16
Wasan, Kishor
14
Mehta, Kapil
12
Ozpolat, Bulent
12
Sanguino, Angela
10
Lin, Yvonne
9
Mangala, Lingegowda
7
Landen, Charles
7
Hung, Mien-Chie
6
Kamat, Aparna
6
McQueen, Teresa
6
Mehta, RT
6
Merritt, William
6
Coleman, Robert
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Gabriel Lopez-Berestein (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Cai You-Qing; Chen Shao-Rui; Han Hee-Dong; Sood Anil K; Lopez-Berestein Gabriel; Pan Hui-Lin
Role of M2, M3, and M4 muscarinic receptor subtypes in the spinal cholinergic control of nociception revealed using siRNA in rats.
Journal of neurochemistry 2009;111(4):1000-10.
-
2009: Vivas-Mejía Pablo E; Ozpolat Bulent; Chen Xian; Lopez-Berestein Gabriel
Downregulation of the c-MYC target gene, peroxiredoxin III, contributes to arsenic trioxide-induced apoptosis in acute promyelocytic leukemia.
International journal of cancer. Journal international du cancer 2009;125(2):264-75.
-
2009: Mangala Lingegowda S; Zuzel Vesna; Schmandt Rosemarie; Leshane Erik S; Halder Jyotsna B; Armaiz-Pena Guillermo N; Spannuth Whitney A; Tanaka Takemi; Shahzad Mian M K; Lin Yvonne G; Nick Alpa M; Danes Christopher G; Lee Jeong-Won; Jennings Nicholas B; Vivas-Mejia Pablo E; Wolf Judith K; Coleman Robert L; Siddik Zahid H; Lopez-Berestein Gabriel; Lutsenko Svetlana; Sood Anil K
Therapeutic Targeting of ATP7B in Ovarian Carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(11):3770-80.
-
2009: Shahzad Mian M K; Lu Chunhua; Lee Jeong-Won; Stone Rebecca L; Mitra Rahul; Mangala Lingegowda S; Lu Yiling; Baggerly Keith A; Danes Christopher G; Nick Alpa M; Halder Jyotsnabaran; Kim Hye-Sun; Vivas-Mejia Pablo; Landen Charles N; Lopez-Berestein Gabriel; Coleman Robert L; Sood Anil K
Dual targeting of EphA2 and FAK in ovarian carcinoma.
Cancer biology & therapy 2009;8(11):1027-34.
-
2009: Feng Shu; Agoulnik Irina U; Li Zhen; Han Hee Dong; Lopez-Berestein Gabriel; Sood Anil; Ittmann Michael M; Agoulnik Alexander I
Relaxin/RXFP1 signaling in prostate cancer progression.
Annals of the New York Academy of Sciences 2009;1160():379-80.
-
2009: Ramachandran Vijaya; Arumugam Thiruvengadam; Langley Robert; Hwang Rosa F; Vivas-Mejia Pablo; Sood Anil K; Lopez-Berestein Gabriel; Logsdon Craig D
The ADMR receptor mediates the effects of adrenomedullin on pancreatic cancer cells and on cells of the tumor microenvironment.
PloS one 2009;4(10):e7502.
-
2009: Mangala Lingegowda S; Han Hee Dong; Lopez-Berestein Gabriel; Sood Anil K
Liposomal siRNA for ovarian cancer.
Methods in molecular biology (Clifton, N.J.) 2009;555():29-42.
-
2008: Gray M J; Dallas N A; Van Buren G; Xia L; Yang A D; Somcio R J; Gaur P; Mangala L S; Vivas-Mejia P E; Fan F; Sanguino A M; Gallick G E; Lopez-Berestein G; Sood A K; Ellis L M
Therapeutic targeting of Id2 reduces growth of human colorectal carcinoma in the murine liver.
Oncogene 2008;27(57):7192-200.
-
2008: Villares Gabriel J; Zigler Maya; Wang Hua; Melnikova Vladislava O; Wu Hong; Friedman Ran; Leslie Michael C; Vivas-Mejia Pablo E; Lopez-Berestein Gabriel; Sood Anil K; Bar-Eli Menashe
Targeting melanoma growth and metastasis with systemic delivery of liposome-incorporated protease-activated receptor-1 small interfering RNA.
Cancer research 2008;68(21):9078-86.
-
2008: Hwang Jee Young; Mangala Lingegowda S; Fok Jansina Y; Lin Yvonne G; Merritt William M; Spannuth Whitney A; Nick Alpa M; Fiterman Derek J; Vivas-Mejia Pablo E; Deavers Michael T; Coleman Robert L; Lopez-Berestein Gabriel; Mehta Kapil; Sood Anil K
Clinical and biological significance of tissue transglutaminase in ovarian carcinoma.
Cancer research 2008;68(14):5849-58.
-
2008: Ozpolat Bulent; Akar Ugur; Zorrilla-Calancha Isabel; Vivas-Mejia Pablo; Acevedo-Alvarez Marian; Lopez-Berestein Gabriel
Death-associated protein 5 (DAP5/p97/NAT1) contributes to retinoic acid-induced granulocytic differentiation and arsenic trioxide-induced apoptosis in acute promyelocytic leukemia.
Apoptosis : an international journal on programmed cell death 2008;13(7):915-28.
-
2008: Akar Ugur; Chaves-Reyez Arturo; Barria Magaly; Tari Ana; Sanguino Angela; Kondo Yasuko; Kondo Seiji; Arun Banu; Lopez-Berestein Gabriel; Ozpolat Bulent
Silencing of Bcl-2 expression by small interfering RNA induces autophagic cell death in MCF-7 breast cancer cells.
Autophagy 2008;4(5):669-79.
-
2008: Yang Lin; Hamilton Stanley R; Sood Anil; Kuwai Toshio; Ellis Lee; Sanguino Angela; Lopez-Berestein Gabriel; Boyd Douglas D
The previously undescribed ZKSCAN3 (ZNF306) is a novel "driver" of colorectal cancer progression.
Cancer research 2008;68(11):4321-30.
-
2008: Verma Amit; Guha Sushovan; Diagaradjane Parmeswaran; Kunnumakkara Ajaikumar B; Sanguino Angela M; Lopez-Berestein Gabriel; Sood Anil K; Aggarwal Bharat B; Krishnan Sunil; Gelovani Juri G; Mehta Kapil
Therapeutic significance of elevated tissue transglutaminase expression in pancreatic cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(8):2476-83.
-
2008: Sanguino Angela; Lopez-Berestein Gabriel; Sood Anil K
Strategies for in vivo siRNA delivery in cancer.
Mini reviews in medicinal chemistry 2008;8(3):248-55.
-
2008: Merritt William M; Lin Yvonne G; Spannuth Whitney A; Fletcher Mavis S; Kamat Aparna A; Han Liz Y; Landen Charles N; Jennings Nicholas; De Geest Koen; Langley Robert R; Villares Gabriel; Sanguino Angela; Lutgendorf Susan K; Lopez-Berestein Gabriel; Bar-Eli Menashe M; Sood Anil K
Effect of interleukin-8 gene silencing with liposome-encapsulated small interfering RNA on ovarian cancer cell growth.
Journal of the National Cancer Institute 2008;100(5):359-72.
-
2008: Gray Michael J; Van Buren George; Dallas Nikolaos A; Xia Ling; Wang Xuemei; Yang Anthony D; Somcio Ray J; Lin Yvonne G; Lim Sherry; Fan Fan; Mangala Lingegowda S; Arumugam Thiruvengadam; Logsdon Craig D; Lopez-Berestein Gabriel; Sood Anil K; Ellis Lee M
Therapeutic targeting of neuropilin-2 on colorectal carcinoma cells implanted in the murine liver.
Journal of the National Cancer Institute 2008;100(2):109-20.
-
2007: Fernández Ariel; Sanguino Angela; Peng Zhenghong; Ozturk Eylem; Chen Jianping; Crespo Alejandro; Wulf Sarah; Shavrin Aleksander; Qin Chaoping; Ma Jianpeng; Trent Jonathan; Lin Yvonne; Han Hee-Dong; Mangala Lingegowda S; Bankson James A; Gelovani Juri; Samarel Allen; Bornmann William; Sood Anil K; Lopez-Berestein Gabriel
An anticancer C-Kit kinase inhibitor is reengineered to make it more active and less cardiotoxic.
The Journal of clinical investigation 2007;117(12):4044-54.
-
2007: Halder Jyotsnabaran; Lin Yvonne G; Merritt William M; Spannuth Whitney A; Nick Alpa M; Honda Toshiyuki; Kamat Aparna A; Han Liz Y; Kim Tae Jin; Lu Chunhua; Tari Ana M; Bornmann William; Fernandez Ariel; Lopez-Berestein Gabriel; Sood Anil K
Therapeutic efficacy of a novel focal adhesion kinase inhibitor TAE226 in ovarian carcinoma.
Cancer research 2007;67(22):10976-83.
-
2007: Landen Charles N; Lin Yvonne G; Armaiz Pena Guillermo N; Das Pamela D; Arevalo Jesusa M; Kamat Aparna A; Han Liz Y; Jennings Nicholas B; Spannuth Whitney A; Thaker Premal H; Lutgendorf Susan K; Savary Cherylyn A; Sanguino Angela M; Lopez-Berestein Gabriel; Cole Steve W; Sood Anil K
Neuroendocrine modulation of signal transducer and activator of transcription-3 in ovarian cancer.
Cancer research 2007;67(21):10389-96.
-
2007: Tari Ana M; Gutiérrez-Puente Yolanda; Monaco Giuseppe; Stephens Clifton; Sun Tong; Rosenblum Michael; Belmont John; Arlinghaus Ralph; Lopez-Berestein Gabriel
Liposome-incorporated Grb2 antisense oligodeoxynucleotide increases the survival of mice bearing bcr-abl-positive leukemia xenografts.
International journal of oncology 2007;31(5):1243-50.
-
2007: Nilsson Monique B; Armaiz-Pena Guillermo; Takahashi Rie; Lin Yvonne G; Trevino Jose; Li Yang; Jennings Nicholas; Arevalo Jesusa; Lutgendorf Susan K; Gallick Gary E; Sanguino Angela M; Lopez-Berestein Gabriel; Cole Steven W; Sood Anil K
Stress hormones regulate interleukin-6 expression by human ovarian carcinoma cells through a Src-dependent mechanism.
The Journal of biological chemistry 2007;282(41):29919-26.
-
2007: Ozpolat Bulent; Akar Ugur; Mehta Kapil; Lopez-Berestein Gabriel
PKC delta and tissue transglutaminase are novel inhibitors of autophagy in pancreatic cancer cells.
Autophagy 2007;3(5):480-3.
-
2007: Cheema Sangeeta K; Gobin Andrea S; Rhea Robyn; Lopez-Berestein Gabriel; Newman Robert A; Mathur Anshu B
Silk fibroin mediated delivery of liposomal emodin to breast cancer cells.
International journal of pharmaceutics 2007;341(1-2):221-9.
-
2007: Fernández Ariel; Sanguino Angela; Peng Zhenghong; Crespo Alejandro; Ozturk Eylem; Zhang Xi; Wang Shimei; Bornmann William; Lopez-Berestein Gabriel
Rational drug redesign to overcome drug resistance in cancer therapy: imatinib moving target.
Cancer research 2007;67(9):4028-33.
-
2007: Akar Ugur; Ozpolat Bulent; Mehta Kapil; Fok Jansina; Kondo Yasuko; Lopez-Berestein Gabriel
Tissue transglutaminase inhibits autophagy in pancreatic cancer cells.
Molecular cancer research : MCR 2007;5(3):241-9.
-
2006: Landen Charles N; Merritt William M; Mangala Lingegowda S; Sanguino Angela M; Bucana Corazon; Lu Chunhua; Lin Yvonne G; Han Liz Y; Kamat Aparna A; Schmandt Rosemarie; Coleman Robert L; Gershenson David M; Lopez-Berestein Gabriel; Sood Anil K
Intraperitoneal delivery of liposomal siRNA for therapy of advanced ovarian cancer.
Cancer biology & therapy 2006;5(12):1708-13.
-
2006: Halder Jyotsnabaran; Kamat Aparna A; Landen Charles N; Han Liz Y; Lutgendorf Susan K; Lin Yvonne G; Merritt William M; Jennings Nicholas B; Chavez-Reyes Arturo; Coleman Robert L; Gershenson David M; Schmandt Rosemarie; Cole Steven W; Lopez-Berestein Gabriel; Sood Anil K
Focal adhesion kinase targeting using in vivo short interfering RNA delivery in neutral liposomes for ovarian carcinoma therapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(16):4916-24.
-
2006: Thaker Premal H; Han Liz Y; Kamat Aparna A; Arevalo Jesusa M; Takahashi Rie; Lu Chunhua; Jennings Nicholas B; Armaiz-Pena Guillermo; Bankson James A; Ravoori Murali; Merritt William M; Lin Yvonne G; Mangala Lingegowda S; Kim Tae Jin; Coleman Robert L; Landen Charles N; Li Yang; Felix Edward; Sanguino Angela M; Newman Robert A; Lloyd Mary; Gershenson David M; Kundra Vikas; Lopez-Berestein Gabriel; Lutgendorf Susan K; Cole Steven W; Sood Anil K
Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma.
Nature medicine 2006;12(8):939-44.
-
2006: Tsimberidou Apostolia-Maria; Tirado-Gomez Maribel; Andreeff Michael; O'Brien Susan; Kantarjian Hagop; Keating Michael; Lopez-Berestein Gabriel; Estey Elihu
Single-agent liposomal all-trans retinoic acid can cure some patients with untreated acute promyelocytic leukemia: an update of The University of Texas M. D. Anderson Cancer Center Series.
Leukemia & lymphoma 2006;47(6):1062-8.
-
2006: Reuben James M; Lee Bang-Ning; Li Changping; Gomez-Navarro Jesus; Bozon Viviana A; Parker Charla A; Hernandez Ingrid M; Gutierrez Carolina; Lopez-Berestein Gabriel; Camacho Luis H
Biologic and immunomodulatory events after CTLA-4 blockade with ticilimumab in patients with advanced malignant melanoma.
Cancer 2006;106(11):2437-44.
-
2005: Ribas Antoni; Camacho Luis H; Lopez-Berestein Gabriel; Pavlov Dmitri; Bulanhagui Cecile A; Millham Robert; Comin-Anduix Begoña; Reuben James M; Seja Elisabeth; Parker Charla A; Sharma Amarnath; Glaspy John A; Gomez-Navarro Jesus
Antitumor activity in melanoma and anti-self responses in a phase I trial with the anti-cytotoxic T lymphocyte-associated antigen 4 monoclonal antibody CP-675,206.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(35):8968-77.
-
2005: Ozpolat Bulent; Mehta Kapil; Lopez-Berestein Gabriel
Regulation of a highly specific retinoic acid-4-hydroxylase (CYP26A1) enzyme and all-trans-retinoic acid metabolism in human intestinal, liver, endothelial, and acute promyelocytic leukemia cells.
Leukemia & lymphoma 2005;46(10):1497-506.
-
2005: Landen Charles N; Chavez-Reyes Arturo; Bucana Corazon; Schmandt Rosemarie; Deavers Michael T; Lopez-Berestein Gabriel; Sood Anil K
Therapeutic EphA2 gene targeting in vivo using neutral liposomal small interfering RNA delivery.
Cancer research 2005;65(15):6910-8.
-
2005: Lu Charles; Perez-Soler Roman; Piperdi Bilal; Walsh Garrett L; Swisher Stephen G; Smythe W Roy; Shin Hyung J; Ro Jae Y; Feng Lei; Truong Mylene; Yalamanchili Adiseshu; Lopez-Berestein Gabriel; Hong Waun K; Khokhar Abdul R; Shin Dong M
Phase II study of a liposome-entrapped cisplatin analog (L-NDDP) administered intrapleurally and pathologic response rates in patients with malignant pleural mesothelioma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(15):3495-501.
-
2005: Estey Elihu; Koller Charles; Tsimberidou Apostolia M; O'Brien Susan; Beran Miloslav; Cortes Jorge; Tirado-Gomez Maribel; Lopez-Berestein Gabriel; Kantarjian Hagop
Potential curability of newly diagnosed acute promyelocytic leukemia without use of chemotherapy: the example of liposomal all-trans retinoic acid.
Blood 2005;105(3):1366-7.
-
2005: Ng Agatha W K; Wasan Kishor M; Lopez-Berestein Gabriel
Liposomal polyene antibiotics.
Methods in enzymology 2005;391():304-13.
-
2004: Harris Michael N; Ozpolat Bulent; Abdi Fadi; Gu Sheng; Legler Allison; Mawuenyega Kwasi G; Tirado-Gomez Maribel; Lopez-Berestein Gabriel; Chen Xian
Comparative proteomic analysis of all-trans-retinoic acid treatment reveals systematic posttranscriptional control mechanisms in acute promyelocytic leukemia.
Blood 2004;104(5):1314-23.
-
2004: Ozpolat Bulent; Tari Ana M; Mehta Kapil; Lopez-Berestein Gabriel
Nuclear retinoid receptors are involved in N-(4-hydroxyphenyl) retinamide (Fenretinide)-induced gene expression and growth inhibition in HL-60 acute myeloid leukemia cells.
Leukemia & lymphoma 2004;45(5):979-85.
-
2004: Siwak Doris R; Tari Ana M; Lopez-Berestein Gabriel
Liposomal antisense oligonucleotides for cancer therapy.
Methods in enzymology 2004;387():241-53.
-
2003: Gutiérrez-Puente Yolanda; Tari Ana M; Ford Richard J; Tamez-Guerra Reyes; Mercado-Hernandez Roberto; Santoyo-Stephano Martha; Lopez-Berestein Gabriel
Cellular pharmacology of P-ethoxy antisense oligonucleotides targeted to Bcl-2 in a follicular lymphoma cell line.
Leukemia & lymphoma 2003;44(11):1979-85.
-
2003: Ozpolat Bulent; Lopez-Berestein Gabriel; Adamson Peter; Fu ChauHwei J; Williams Anthony H
Pharmacokinetics of intravenously administered liposomal all-trans-retinoic acid (ATRA) and orally administered ATRA in healthy volunteers.
Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Société canadienne des sciences pharmaceutiques 2003;6(2):292-301.
-
2003: Cheema Sangeeta K; Mishra Sandip K; Rangnekar Vivek M; Tari Ana M; Kumar Rakesh; Lopez-Berestein Gabriel
Par-4 transcriptionally regulates Bcl-2 through a WT1-binding site on the bcl-2 promoter.
The Journal of biological chemistry 2003;278(22):19995-20005.
-
2003: Ng Agatha W K; Wasan Kishor M; Lopez-Berestein Gabriel
Development of liposomal polyene antibiotics: an historical perspective.
Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Société canadienne des sciences pharmaceutiques 2003;6(1):67-83.
-
2002: Bernstein Zale P; Chanan-Khan Asher; Miller Kena C; Northfelt Donald W; Lopez-Berestein Gabriel; Gill Parkash S
A multicenter phase II study of the intravenous administration of liposomal tretinoin in patients with acquired immunodeficiency syndrome-associated Kaposi's sarcoma.
Cancer 2002;95(12):2555-61.
-
2002: Tari Ana M; Lim Soo-Jeong; Hung Mien-Chie; Esteva Francisco J; Lopez-Berestein Gabriel
Her2/neu induces all-trans retinoic acid (ATRA) resistance in breast cancer cells.
Oncogene 2002;21(34):5224-32.
-
2002: Zapata-Benavides Pablo; Tuna Musaffe; Lopez-Berestein Gabriel; Tari Ana M
Downregulation of Wilms' tumor 1 protein inhibits breast cancer proliferation.
Biochemical and biophysical research communications 2002;295(4):784-90.
-
2002: Ozpolat B; Lopez-Berestein G
Liposomal-all-trans-retinoic acid in treatment of acute promyelocytic leukemia.
Leukemia & lymphoma 2002;43(5):933-41.
-
2002: Ozpolat Bulent; Mehta Kapil; Tari Ana M; Lopez-Berestein Gabriel
all-trans-Retinoic acid-induced expression and regulation of retinoic acid 4-hydroxylase (CYP26) in human promyelocytic leukemia.
American journal of hematology 2002;70(1):39-47.
-
2002: Milella Michele; Estrov Zeev; Kornblau Steven M; Carter Bing Z; Konopleva Marina; Tari Ana; Schober Wendy D; Harris David; Leysath Clinton E; Lopez-Berestein Gabriel; Huang Ziwei; Andreeff Michael
Synergistic induction of apoptosis by simultaneous disruption of the Bcl-2 and MEK/MAPK pathways in acute myelogenous leukemia.
Blood 2002;99(9):3461-4.
-
2002: Siwak Doris R; Tari Ana M; Lopez-Berestein Gabriel
The potential of drug-carrying immunoliposomes as anticancer agents. Commentary re: J. W. Park et al., Anti-HER2 immunoliposomes: enhanced efficacy due to targeted delivery. Clin. Cancer Res., 8: 1172-1181, 2002.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(4):955-6.
-
2001: Tari A M; Lopez-Berestein G
Cellular uptake of antisense oligonucleotides.
Current opinion in investigational drugs (London, England : 2000) 2001;2(10):1450-3.
-
2001: Tari A M; Lopez-Berestein G
GRB2: a pivotal protein in signal transduction.
Seminars in oncology 2001;28(5 Suppl 16):142-7.
-
2001: Hortobagyi G N; Ueno N T; Xia W; Zhang S; Wolf J K; Putnam J B; Weiden P L; Willey J S; Carey M; Branham D L; Payne J Y; Tucker S D; Bartholomeusz C; Kilbourn R G; De Jager R L; Sneige N; Katz R L; Anklesaria P; Ibrahim N K; Murray J L; Theriault R L; Valero V; Gershenson D M; Bevers M W; Huang L; Lopez-Berestein G; Hung M C
Cationic liposome-mediated E1A gene transfer to human breast and ovarian cancer cells and its biologic effects: a phase I clinical trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(14):3422-33.
-
2001: Ozpolat B; Lopez-Berestein G; Mehta K
ATRA(ouble) in the treatment of acute promyelocytic leukemia.
Journal of biological regulators and homeostatic agents 2001;15(2):107-22.
-
2000: Lim S J; Lopez-Berestein G; Hung M C; Lupu R; Tari A M
Grb2 downregulation leads to Akt inactivation in heregulin-stimulated and ErbB2-overexpressing breast cancer cells.
Oncogene 2000;19(54):6271-6.
-
1999: Gutiérrez-Puente Y; Tari A M; Stephens C; Rosenblum M; Guerra R T; Lopez-Berestein G
Safety, pharmacokinetics, and tissue distribution of liposomal P-ethoxy antisense oligonucleotides targeted to Bcl-2.
The Journal of pharmacology and experimental therapeutics 1999;291(2):865-9.
-
1999: Estey E H; Giles F J; Kantarjian H; O'Brien S; Cortes J; Freireich E J; Lopez-Berestein G; Keating M
Molecular remissions induced by liposomal-encapsulated all-trans retinoic acid in newly diagnosed acute promyelocytic leukemia.
Blood 1999;94(7):2230-5.
-
1999: Ueno N T; Xia W; Tucker S D; Zhang S; Lopez-Berestein G; Huang L; Hung M C
Issues in the development of gene therapy: preclinical experiments in E1A gene delivery.
Oncology reports 1999;6(2):257-62.
-
1999: Tari A M; Hung M C; Li K; Lopez-Berestein G
Growth inhibition of breast cancer cells by Grb2 downregulation is correlated with inactivation of mitogen-activated protein kinase in EGFR, but not in ErbB2, cells.
Oncogene 1999;18(6):1325-32.
-
1998: Hortobagyi G N; Hung M C; Lopez-Berestein G
A Phase I multicenter study of E1A gene therapy for patients with metastatic breast cancer and epithelial ovarian cancer that overexpresses HER-2/neu or epithelial ovarian cancer.
Human gene therapy 1998;9(12):1775-98.
-
1998: Tormo M; Tari A M; McDonnell T J; Cabanillas F; Garcia-Conde J; Lopez-Berestein G
Apoptotic induction in transformed follicular lymphoma cells by Bcl-2 downregulation.
Leukemia & lymphoma 1998;30(3-4):367-79.
-
1997: Beham A; Marin M C; Fernandez A; Herrmann J; Brisbay S; Tari A M; Lopez-Berestein G; Lozano G; Sarkiss M; McDonnell T J
Bcl-2 inhibits p53 nuclear import following DNA damage.
Oncogene 1997;15(23):2767-72.
-
1997: Sundaresan A; Claypool K; Mehta K; Lopez-Berestein G; Cabanillas F; Ford R J
Retinoid-mediated inhibition of cell growth with stimulation of apoptosis in aggressive B-cell lymphomas.
Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research 1997;8(10):1071-82.
-
1997: Tari A M; Arlinghaus R; Lopez-Berestein G
Inhibition of Grb2 and Crkl proteins results in growth inhibition of Philadelphia chromosome positive leukemic cells.
Biochemical and biophysical research communications 1997;235(2):383-8.
-
1997: Xing X; Liu V; Xia W; Stephens L C; Huang L; Lopez-Berestein G; Hung M C
Safety studies of the intraperitoneal injection of E1A--liposome complex in mice.
Gene therapy 1997;4(3):238-43.
-
1997: Wasan K M; Lopez-Berestein G
Diversity of lipid-based polyene formulations and their behavior in biological systems.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1997;16(1):81-92.
-
1996: Estey E; Thall P F; Mehta K; Rosenblum M; Brewer T; Simmons V; Cabanillas F; Kurzrock R; Lopez-Berestein G
Alterations in tretinoin pharmacokinetics following administration of liposomal all-trans retinoic acid.
Blood 1996;87(9):3650-4.
-
1996: Tari A; Khodadadian M; Ellerson D; Deisseroth A; Lopez-Berestein G
Liposomal delivery of oligodeoxynucleotides.
Leukemia & lymphoma 1996;21(1-2):93-7.
-
1996: Vadiei K; Tucker S D; Lopez-Berestein G; Wasan K M
Nephroprotective mechanism(s) of pentoxifylline: reduction of erythrocyte-mediated vascular congestion and inhibition of nitric oxide release.
Pharmacology & toxicology 1996;78(3):174-80.
-
1994: Wasan K M; Grossie V B; Lopez-Berestein G
Concentrations in serum and distribution in tissue of free and liposomal amphotericin B in rats during continuous intralipid infusion.
Antimicrobial agents and chemotherapy 1994;38(9):2224-6.
-
1994: Mehta K; Sadeghi T; McQueen T; Lopez-Berestein G
Liposome encapsulation circumvents the hepatic clearance mechanisms of all-trans-retinoic acid.
Leukemia research 1994;18(8):587-96.
-
1994: Newell C L; Deisseroth A B; Lopez-Berestein G
Interaction of nuclear proteins with an AP-1/CRE-like promoter sequence in the human TNF-alpha gene.
Journal of leukocyte biology 1994;56(1):27-35.
-
1994: Tari A M; Tucker S D; Deisseroth A; Lopez-Berestein G
Liposomal delivery of methylphosphonate antisense oligodeoxynucleotides in chronic myelogenous leukemia.
Blood 1994;84(2):601-7.
-
1994: Wasan K M; Morton R E; Rosenblum M G; Lopez-Berestein G
Decreased toxicity of liposomal amphotericin B due to association of amphotericin B with high-density lipoproteins: role of lipid transfer protein.
Journal of pharmaceutical sciences 1994;83(7):1006-10.
-
1994: Wasan K M; Hayman A C; Lopez-Berestein G
Determination of dimyristoylphosphatidylglycerol in human serum by liquid-liquid extraction and reversed-phase liquid chromatography.
Journal of pharmaceutical and biomedical analysis 1994;12(6):851-4.
-
1994: Wasan K M; Grossie V B; Lopez-Berestein G
Effects of intralipid infusion on rat serum lipoproteins.
Laboratory animals 1994;28(2):138-42.
-
1994: Wasan K M; Rosenblum M G; Cheung L; Lopez-Berestein G
Influence of lipoproteins on renal cytotoxicity and antifungal activity of amphotericin B.
Antimicrobial agents and chemotherapy 1994;38(2):223-7.
-
1993: Drach J; Lopez-Berestein G; McQueen T; Andreeff M; Mehta K
Induction of differentiation in myeloid leukemia cell lines and acute promyelocytic leukemia cells by liposomal all-trans-retinoic acid.
Cancer research 1993;53(9):2100-4.
-
1993: Wasan K M; Brazeau G A; Keyhani A; Hayman A C; Lopez-Berestein G
Roles of liposome composition and temperature in distribution of amphotericin B in serum lipoproteins.
Antimicrobial agents and chemotherapy 1993;37(2):246-50.
-
1992: Luke D R; Brunner L J; Lopez-Berestein G; Yau J C
Pharmacokinetics of cyclosporine in bone marrow transplantation: longitudinal characterization of drug in lipoprotein fractions.
Journal of pharmaceutical sciences 1992;81(3):208-11.
-
1992: Luke D R; Vadiei K; Lopez-Berestein G
Role of vascular congestion in cisplatin-induced acute renal failure in the rat.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1992;7(1):1-7.
-
1991: Mehta R T; McQueen T J; Keyhani A; Lopez-Berestein G
Liposomal hamycin: reduced toxicity and improved antifungal efficacy in vitro and in vivo.
The Journal of infectious diseases 1991;164(5):1003-6.
-
1991: Tucker S D; Sivaramakrishnan M R; Klostergaard J; Lopez-Berestein G
Independence of the pattern of early cytokine release from autoregulation by nitric oxide.
Journal of leukocyte biology 1991;50(5):509-16.
-
1991: Wasan K M; Vadiei K; Luke D R; Keyhani A; White R A; McQueen T J; Mehta R; Lopez-Berestein G
Antifungal activity of HWA-138 and amphotericin B in experimental systemic candidiasis.
Antimicrobial agents and chemotherapy 1991;35(10):2046-8.
-
1991: Luke D R; Wasan K M; Verani R R; Brunner L J; Berens K L; Vadiei K; Lopez-Berestein G
Attenuation of amphotericin-B nephrotoxicity in the candidiasis rat model.
Nephron 1991;59(1):139-44.
-
1991: Yau J C; Brunner L J; Lopez-Berestein G; LeMaistre C F; Luke D R
Therapeutic drug monitoring of cyclosporine-lipoprotein levels.
Pharmacotherapy 1991;11(4):291-5.
-
1990: Turpin J; Mehta K; Blick M; Hester J P; Lopez-Berestein G
Effect of retinoids on the release and gene expression of tumor necrosis factor-alpha in human peripheral blood monocytes.
Journal of leukocyte biology 1990;48(5):444-50.
-
1990: Howard O M; Talpaz M; Kantarjian H; Seong D; Wedrychowski A; Paslidis N; Hester J; Cork A; Turpin J; Lopez-Berestein G
Interferon affects nuclear proteins in cells of clinically sensitive chronic myelogenous leukemia patients.
Blood 1990;76(6):1117-30.
-
1990: Langston J D; Wasan K M; Lopez-Berestein G; Verani R R; Luke D R
Evaluation of amphotericin B-cyclosporine interaction in the rat.
Transplantation 1990;50(3):506-10.
-
1990: Perez-Soler R; Lopez-Berestein G; Lautersztain J; al-Baker S; Francis K; Macias-Kiger D; Raber M N; Khokhar A R
Phase I clinical and pharmacological study of liposome-entrapped cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexane platinum(II).
Cancer research 1990;50(14):4254-9.
-
1990: Luke D R; Wasan K M; McQueen T J; Lopez-Berestein G
Enhancement of the treatment of experimental candidiasis with vascular decongestants.
The Journal of infectious diseases 1990;162(1):211-4.
-
1990: Vadiei K; Lopez-Berestein G; Luke D R
Disposition and toxicity of amphotericin-B in the hyperlipidemic Zucker rat model.
International journal of obesity 1990;14(6):465-72.
-
1990: Wasan K M; Vadiei K; Lopez-Berestein G; Luke D R
Pharmacokinetics, tissue distribution, and toxicity of free and liposomal amphotericin B in diabetic rats.
The Journal of infectious diseases 1990;161(3):562-6.
-
1990: Wasan K M; Vadiei K; Lopez-Berestein G; Verani R R; Luke D R
Pentoxifylline in amphotericin B toxicity rat model.
Antimicrobial agents and chemotherapy 1990;34(2):241-4.
-
1990: Kilbourn R; Lopez-Berestein G
Protease inhibitors block the macrophage-mediated inhibition of tumor cell mitochondrial respiration.
Journal of immunology (Baltimore, Md. : 1950) 1990;144(3):1042-5.
-
1989: Midez J A; Hopfer R L; Lopez-Berestein G; Mehta R T
Effects of free and liposomal amphotericin B and gramicidin S alone and in combination on potassium leakage from human erythrocytes and Candida albicans.
Antimicrobial agents and chemotherapy 1989;33(2):152-5.
-
1989: Mehta R T; Hopfer R L; Juliano R L; Lopez-Berestein G
A comparison of in vitro toxicity and antifungal efficacy of membrane-active drugs after liposome encapsulation.
Selective cancer therapeutics 1989;5(3):113-7.
-
1988: Murray J L; Mehta K; Lopez-Berestein G
Induction of adenosine deaminase and 5' nucleotidase activity in cultured human blood monocytes and monocytic leukemia (THP-1) cells by differentiating agents.
Journal of leukocyte biology 1988;44(3):205-11.
-
1988: Lautersztain J; Perez-Soler R; Turpin J; Khokhar A R; Siddik Z H; Schmidt K; Lopez-Berestein G
Cellular pharmacology of liposomal cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexaneplatinum (II) in mouse resident peritoneal macrophages, Kupffer cells, and hepatocytes.
Cancer research 1988;48(5):1300-6.
-
1987: Mehta R T; Hopfer R L; McQueen T; Juliano R L; Lopez-Berestein G
Toxicity and therapeutic effects in mice of liposome-encapsulated nystatin for systemic fungal infections.
Antimicrobial agents and chemotherapy 1987;31(12):1901-3.
-
1987: Mehta R T; Hopfer R L; Gunner L A; Juliano R L; Lopez-Berestein G
Formulation, toxicity, and antifungal activity in vitro of liposome-encapsulated nystatin as therapeutic agent for systemic candidiasis.
Antimicrobial agents and chemotherapy 1987;31(12):1897-900.
-
1987: Perez-Soler R; Khokhar A R; Lopez-Berestein G
Treatment and prophylaxis of experimental liver metastases of M5076 reticulosarcoma with cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexaneplatinum (II) encapsulated in multilamellar vesicles.
Cancer research 1987;47(24 Pt 1):6462-6.
-
1986: Lautersztain J; Perez-Soler R; Khokhar A R; Newman R A; Lopez-Berestein G
Pharmacokinetics and tissue distribution of liposome-encapsulated cis-bis-N-decyl-iminodiacetato-1,2-diaminocyclohexane-platinum (II).
Cancer chemotherapy and pharmacology 1986;18(2):93-7.
-
1985: Mehta R T; Lopez-Berestein G; Hopfer R L; Mehta K; White R A; Juliano R L
Prophylaxis of murine candidiasis via application of liposome-encapsulated amphotericin B and a muramyl dipeptide analog, alone and in combination.
Antimicrobial agents and chemotherapy 1985;28(4):511-3.
Sign-in to see more
